Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Robotic versus laparoscopic urological surgery: incidence of reoperation and complications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Microwawe ablation of renal cell carcinoma: initial safety and evaluation of loss of function in the treated kidney

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  • Harry Nisen
  • Petrus Järvinen
  • Magnus Fovaeus
  • Eirikur Guðmundsson
  • Bjarne Kromann-Andersen
  • Börje Ljungberg
  • Lars Lund
  • Frode Nilsen
  • Pernilla Sundqvist
  • Christian Beisland
Vis graf over relationer

OBJECTIVE: The five Nordic countries comprise 25 million people, and have similar treatment traditions and healthcare systems. To take advantage of these similarities, a collaborative group (Nordic Renal Cancer Group, NORENCA) was founded in 2015.

MATERIALS AND METHODS: A questionnaire of 17 questions on renal tumor management and surgical education was designed and sent to 91 institutions performing renal tumor surgery in 2015. The response rate was 68% (62 hospitals), including 28 academic, 25 central and nine district hospitals. Hospital volume was defined as low (LVH: < 20 operations), intermediate (IVH: 20-49 operations), high (HVH: 50-99) and very high (VHVH: ≥ 100). Descriptive statistics were performed.

RESULTS: Fifteen centers were LVH, 16 IVH, 21 HVH and 10 VHVH. Of all 3828 kidney tumor treatments, 55% were radical nephrectomies (RNs), 37% partial nephrectomies (PNs) and 8% thermoablations. For RN and PN, the percentages of open, laparoscopic and robotic approaches were 47%, 40%, 13% and 47%, 20%, 33%, respectively. The mean complication rate (Clavien-Dindo 3-5) was 4.9%, and 30 day mortality (TDM) was 0.5%. The median length of hospital stay was 4 days. Training with a simulator, black box or animal laboratory was possible in 48%, 74% and 21% of institutions, respectively.

CONCLUSIONS: Despite some differences between countries, the data suggest an overall general common Nordic treatment attitude for renal tumors. Furthermore, the data demonstrate high adherence to international standards, with a high proportion of PN and acceptable rates for major complications and TDM.

TidsskriftScandinavian Journal of Urology
Udgave nummer6
Sider (fra-til)360-366
Antal sider7
StatusUdgivet - okt. 2017

ID: 51443224